AKVAPROSJEKTER AS

Keywords

researchdevelopment workbiotechnologygenomicspharmageneticsgene samplesdna sequencingdna synthesisdna deepeninggenetic engineeringproteinsmoleculespeptide sequencinglipidglycotechniqueproteomicshormonesgrowth factorscell receptorspheromonescell culturetissue culturecrossingcell fusionvaccineimmunostimulatorsembryo manipulationprocess biotechnologybioreactorsfermentationbioprocessingbiorecoverybiodesulfurizationbiological pulp productionbiofiltrationbiological regenerationsubcellular organismsgene therapyvirusesvectors

Organization

CEO: IG
Ivar Gulla1968
Chairman of the board: IG
Ivar Gulla1968
Years since formation: 1 year; since Sep 6, 2023
Type: Limited company
VAT registered: No
Number of employees: 0

Ownership

Number of shares and share classes: 100,000; 1 share class
Total number of shareholders: 1; company
Belongs to group of

Financials

Annual total result 2023: 325,899; NOK
Total equity 2023: 4,721,821; NOK

Last update: Sep 12, 2024

Management

Management / administration

Name	Role	Shares
IG Ivar Gulla 1968	Managing Director/CEO	100 % indirectly

Board

Name	Role	Shares
IG Ivar Gulla 1968	Chairman	100 % indirectly

Others

Name	Role	Shares
P PRAVDA ACCOUNTING AS	Accountant	-

Top 10 individual shareholders

Name	Role	Shares
IG Ivar Gulla 1968	Managing Director/CEO, Chairman	100 % indirectly

Last update: Sep 11, 2023

Ownership

Company shareholders

Name	Share class	Number of shares	Share
G GULLA HOLDING AS	Ordinary shares	100,000	100 %

Shares owned by the AKVAPROSJEKTER AS

Name	Share class	Number of shares	Share
B BLÅ BIOTEK AS	Ordinary shares	150	100 %
P PROPHYLAXIA AS	Ordinary shares	22,526	16.65 %
P PROPHYLAXIA SIGNS AS	Ordinary shares	15,300	10.2 %
I IRSEA ARC AS	Ordinary shares	20,000	10 %
S SESSLAKS AS	Ordinary shares	20	2 %
E EIKLAKS AS	Ordinary shares	40	2 %
A AURELAKS AS	Ordinary shares	40	2 %

Last update: May 24, 2024

Group structure

GULLA HOLDING AS
Total operating income 2023: NOK 0
Operating profit 2023: NOK -8,728
Employees: 0

Financials

in NOK

Summary

Year	2023
Total operating income	0
Annual Total Result	325,899
Total assets	8,092,547
Total liabilities	3,370,726
Total equity	4,721,821

P&L

Year	2023
Total operating income	0
Total operating costs	816
Operating result	-816
Financial income/costs	419,706
Profit before tax	418,890
Total tax & extraordinary income/cost	92,991
Annual Total Result	325,899

Balance overview

Year	2023
Total fixed assets	8,069,386
Total current assets	23,161
Total assets	8,092,547
Short term debt	922,187
Long term debt	2,448,539
Total liabilities	3,370,726
Contributed capital	4,762,396
Retained earnings	-40,575
Total equity	4,721,821
Total equity and liabilities	8,092,547

AKVAPROSJEKTER AS932 022 389